Studies in yeast demonstrate that signaling kinases have a surprisingly active role in the nucleus, where they tether to chromatin and modulate gene expression programs. Despite these seminal studies, the nuclear mechanism of how signaling kinases control transcription of mammalian genes is in its infancy.
INTRODUCTION
Intracellular signal transduction often involves a complex cascade of phosphorylation events that enable cells to respond appropriately to extracellular stimuli. Kinases play a crucial role in these signaling pathways as they transiently associate with binding partners and transfer phosphate groups onto target substrates. The activation and concerted action of such proteins provides the exquisite control necessary for the initiation of specific transcription programs. Traditionally, the action of signaling kinases was thought to occur predominantly in the cytoplasm. Pioneering studies in yeast, however, have shown that signal transduction kinases translocate to the nucleus and stably associate with the promoter and transcribed regions of genes to regulate expression (Pascual-Ahuir et al., 2006; Pokholok et al., 2006) . These chromatin-tethered kinases have been shown to have both a structural role as part of transcription complexes, as well as an enzymatic role by phosphorylating their target proteins (de Nadal and Posas, 2010; Edmunds and Mahadevan, 2006) .
There is growing evidence in higher eukaryotes that signal transduction kinases can exhibit a distinct function in both the cytoplasm and the nucleus. For example, upstream kinases of the NF-kB pathway, IKK1 and NIK, shuttle between the cytoplasm and nucleus in resting cells to facilitate basal NF-kB transcriptional activity (Birbach et al., 2002) . IKK-a was shown to have an alternative role as a histone kinase that directly phosphorylates H3S10 at the promoters of NF-kB-responsive genes (Anest et al., 2003; Yamamoto et al., 2003) . The p38 mitogenactivated protein kinase (MAPK) is another signaling kinase that is recruited to the chromatin of muscle-specific loci where it targets the SWI-SNF chromatin remodeling complex (Simone et al., 2004) . It has also been demonstrated that inflammatory stimuli signal via p38 to chromatin (Saccani et al., 2002) .
Translocation of signaling kinases to the nucleus could provide an efficient mechanism whereby cells communicate extracellular signals generated at the plasma membrane to the nucleus. Indeed, PKC isozymes have been shown to be capable of residency within the nucleus (Martelli et al., 1999) , and it has been known for some time that these kinases can phosphorylate histones in vitro (Inoue et al., 1977; Yu et al., 1998) . Some of the nuclear substrates identified for PKCs in vivo include DNA topoisomerase I, lamin B, myogenin, nucleolin, p53, TdT and the vitamin D 3 receptor (Martelli et al., 1999) . Importantly, phosphoinositide signaling, which is central to the PKC activation pathway, appears to be intact at both the plasma membrane and in the nucleus (Visnjic and Banfic, 2007) . Despite increasing evidence that PKC signaling kinases localize to the nucleus, their nuclear-specific functions and substrate specificities have remained unclear. The Ca 2+ -independent PKC isoform, PKC-q, has previously been shown to associate with centrosomes and kinetochore structures of the mitotic spindle within the nucleus of murine erythroleukemia cells (Passalacqua et al., 1999) . This kinase is best known for its critical role in efficient T cell activation (Isakov and Altman, 2002) and for its importance in proliferation, differentiation, and survival of mature T cells (Hayashi and Altman, 2007) . Dysregulation of the PKC family has also been implicated in pathologies such as cancer and tumor metastasis (Griner and Kazanietz, 2007; Martiny-Baron and Fabbro, 2007) .
Here, we demonstrate a nuclear role for PKC-q as a component of an activating transcriptional complex in human T cells. We have shown that PKC-q physically associates with the proximal promoter and coding regions of immune response genes after T cell activation. Chromatin-tethered PKC-q is intimately associated with the presence of RNA polymerase II, the histone kinase MSK-1, and the adaptor protein 14-3-3z. This event appears to be coupled with PKC-q catalytic activity. ChIP-onchip showed that PKC-q also localizes to the regulatory regions of a distinct cluster of microRNAs and negatively regulates their transcription. These findings exemplify a more general role for signaling kinases as regulators of gene transcription in mammalian cells that act by two distinct mechanisms: (1) cytoplasmic signaling to the nucleus and (2) direct association with chromatin-bound transcription complexes at activated target genes in the nucleus.
RESULTS

PKC-q Localizes in the Nucleus of T Cells and Coresides with Active Chromatin
To determine whether PKC-q resides in the nucleus of human T cells, we performed immunoblot of nuclear extracts from Jurkat T cells that were either untreated or stimulated with phorbol 12-myristate 13-acetate/calcium ionomycin (P/I). PKC-q was present in the nucleus of both nonstimulated (NS) and P/I-stimulated (ST) T cells ( Figure 1A) . To confirm the purity of nuclear preparations, we carried out immunofluorescence staining for the nonnuclear antigen, Integrin b 1 , which was excluded from the isolated T cell nuclei ( Figure 1B ). Nuclear PKC-q was localized to the weakly DAPI-stained euchromatic compartment, in both resting and activated T cells (data not shown). Consistent with the detection of PKC-q in the euchromatin fraction, this kinase coresided with RNA polymerase II (denoted Pol II herein) in activated T cells ( Figure 1C ). In contrast, PKC-q did not colocalize with the repressive mark heterochromatin protein 1-a (HP1a) or the heterochromatic histone modification, dimethylation of lysine-9 of histone H3 (H3K9me2) ( Figure 1C ). PKC kinase assays confirmed catalytic activity of PKC in the nucleus and in whole T cells prior to and after T cell activation ( Figure 1D ). PKC-q halfway ChIP on T cell nuclear extracts showed an asso-ciation between endogenous PKC-q and histones H3 and H4 in T cells ( Figure 1E ). Additionally, PKC-q associates with two indicators of active chromatin, Pol II and histone H3 acetylated at lysine-9 (H3K9ac) ( Figure 1F ). The anti-phospho-Pol II antibody recognizes this protein when it is phosphorylated at serine-5 (denoted anti-Pol IIp herein). PKC-q failed to coimmunoprecipite the repressive marks H2A.Z and HP1-a (data not shown). Taken together, nuclear PKC-q exists in the proximity of nucleosomes within active chromatin.
PKC-q Is Preferentially Recruited to the Regulatory Regions of Activated Genes and Forms a Nuclear
Complex with Pol II and MSK-1 in Human T Cells Since PKC-q colocalized in the vicinity of nucleosomes in both resting and activated T cells, we investigated whether PKC-q functions as a chromatin-tethered kinase, similar to those recently reported (Pokholok et al., 2006; Proft et al., 2006) . Sequential ChIP showed increased co-occupancy between histone H3 not only with PKC-q and catalytically active PKC-q (denoted as PKC-qp herein), but also with the histone kinase MSK-1 on the CD69 proximal promoter in activated T cells (ST) (Figure 2A ). PKC-q and MSK-1 were also found to coexist on this stretch of DNA in activated T cells ( Figure 2B) . A stimulusdependent increase in PKC-q recruitment was observed across the CD69 gene, with maximal occupancy detected at +0.5 Kb in the 5 0 -transcribed region following 24 hr of P/I activation (Figure 2C) . Similarly, a transient increase in MSK-1 occupancy was detected across the CD69 gene, with levels peaking at +0.5 Kb in the transcribed region following 4 hr of P/I (Figure 2D) . PKC-q and MSK-1 occupancy were also detected in resting T cells in the 5 0 -transcribed region ( Figures 2C and 2D ), which may reflect basal transcription of this gene (Sutcliffe et al., 2009 ). PKC-q catalytic activity is substantially influenced by phosphorylation of serine-695 in its hydrophobic motif (Liu et al., 2002) . A transient increase was observed in active PKC-qp (phosphorylated serine-695) at the CD69 promoter after 4 hr P/I ( Figure 2E ). Recruitment of PKC-qp was closely coupled to the early stages of transcriptional activation at the CD69 promoter, while being sustained in the 5 0 -transcribed region (Figure 2E) . Recruitment of Pol II to gene promoters and coding regions is a well-characterized mark of active gene transcription. Sequential ChIP revealed increased co-occupancy of both PKC-q and MSK-1 with Pol II on the CD69 gene promoter in activated T cells ( Figure 2F ). These data suggest that PKC-q exists as part of an active transcriptional complex on chromatin with MSK-1 and Pol II on the CD69 gene.
We next interrogated by ChIP whether PKC-q associated with the promoters of CD69, heparanase, tumor necrosis factor-alpha (TNF-a), and interferon-gamma (IFN-g). These genes were chosen for their inducibility in T cells and for their critical immune functions, while the constitutively expressed GAPDH gene was used for comparison. Levels of PKC-q occupancy at the proximal promoters of all genes increased in a stimulus-dependent manner, except for GAPDH (Table 1) . Affymetrix profiling microarray data showed that Jurkat T cells closely mimic naive human CD4 + T cells, as they share at least 85% of their transcriptome (data not shown). To further assess that PKC-q associates with chromatin, we performed ChIP on ex vivo-derived human primary CD4 + T cell subsets (Figure S1 available online), namely naive, resting, effector, and activated memory. PKC-q was enriched predominantly in the effector and activated memory pop-ulations on the human IL-2 promoter ( Figure 2G) , consistent with recent studies implicating this kinase in T cell memory (Marsland et al., 2005) . Furthermore, H3K9ac occupancy on the IL-2 promoter was similarly enriched in the memory T cell subsets over the naive subset ( Figure 2H ), consistent with PKC-q primarily associating with active chromatin and the recent observations in human CD8 + memory T cells (Araki et al., 2008) . This chromatin profile was mirrored at the transcript level, whereby IL-2 was expressed at the highest levels in the effector and activated memory populations ( Figure 2I ). To complement the PKC-q staining profile in Jurkat T cells ( Figure 1C ), an accumulation of PKC-q was observed in the euchromatin fraction in ex vivo derived human CD4 + T cells ( Figure 2J ). Less nuclear PKC-q was detected in resting memory T cells compared to the other memory subsets ( Figure 2J ), which parallels the ChIP enrichments across these cells ( Figure 2G ). These data support the view that human PKC-q selectively associates with the promoters of activated immune response genes in human T cells.
PKC-q Recruitment Correlates with the Active Transcription of Inducible Genes
To assess the time-dependence of PKC-q recruitment after continuous T cell activation, an experiment was designed (schematically depicted in Figure 3A ) to measure CD69, TNF-a, and IFN-g gene transcription and the presence of PKC-q and MSK-1 on these gene promoters before (NS), during (ST), and after (cells were washed extensively five times to remove the stimulus; SW) T cell activation. Consistent with our previous observations, transcripts were all induced after 4 hr of T cell activation ( Figure 3A ). After stimulus removal, transcript levels of all of these genes diminished, albeit to different extents ( Figure 3A ). Occupancy profiles of PKC-q and MSK-1 paralleled active transcription of these genes ( Figures 3B and 3C , respectively), with no MSK-1 detected on these promoters after stimulus removal ( Figure 3C ). Previous studies have shown that the histone variant H2A.Z is preferentially enriched on transcriptionally inactive promoters and depleted from highly transcribed genes. Accordingly, the deposition of H2A.Z at these gene promoters was inversely correlated with active gene transcription ( Figure 3D ). As expected, Pol IIp recruitment to these promoters increased transiently after activation and diminished after stimulus withdrawal ( Figure 3E ), consistent with the recruitment profiles of PKC-q and MSK-1. These data suggest that PKC-q and MSK-1 require the continual presence of activating signals to maintain their association with chromatin.
PKC-q Colocalizes with the Adaptor Molecule 14-3-3z on Transcriptionally Active Genes Previous studies have shown that PKC-q and 14-3-3 adaptor family members are interacting partners (Meller et al., 1998) . The 14-3-3z adaptor protein interacts with chromatin by binding to H3S10p, and this event is a prerequisite for inducible gene regulation (Winter et al., 2008) . Halfway ChIP on nuclear extracts showed that 14-3-3z associates with histone H3 ( Figure 4A ) and PKC-q ( Figure 4B ) in NS and in 4 hr-activated T cells. ChIP revealed that this adaptor protein is recruited in a stimulus-dependent manner to the CD69 and TNF-a gene promoters with maximal occupancy at 8 hr after T cell activation ( Figure 4C ). Sequential ChIP with antibodies against PKC-qp and 14-3-3z revealed the coexistence of these proteins on both the CD69 and TNF-a gene promoters and this association increased in a stimulus-dependent manner ( Figure 4D ).
To delineate the association of PKC-q with 14-3-3z or Pol II on inducible genes, we performed ChIPs on T cells transiently transfected with a PKC-q overexpression construct (WT), a PKC-q catalytically inactive mutant (KR), and a vector only (V) construct control. ChIP showed increased PKC-q recruitment to the CD69 and heparanase promoters in WT cells compared to the vector control (Figures 4E) . Consistent with studies of the catalytically inactive form of the yeast Hog1 kinase, which was unable to engage with gene promoters (Alepuz et al., 2001) , the PKC-q KR mutant also failed to associate with inducible gene promoters (Figures 4E) . The inability of the PKC-q KR mutant to be recruited onto inducible gene promoters cannot be attributed to lack of nuclear localization, since overexpression of both the Histagged PKC-q KR mutant and His-PKC-q displayed similar nuclear distribution in Jurkat T cells (data not shown). Binding profiles of 14-3-3z and Pol II closely mirrored those of PKC-q observed for WT and KR mutant samples (Figures 4E) . These data demonstrate that binding of 14-3-3z and Pol II are dependent on catalytically active PKC-q. Thus, in addition to MSK-1 and Pol II, PKC-q also appears to form a complex with 14-3-3z at the promoters of activated genes in T cells.
Chromatin-Tethered PKC-q Forms an Active Transcription Complex that Regulates Chromatin Accessibility, but Not H3S10p at the Promoters of Inducible Genes The nucleosomal kinase MSK-1 mediates serine-10 phosphorylation of histone H3 (H3S10p) on immediate-early response genes, with this motif acting as a code for the recruitment of 14-3-3z (Winter et al., 2008) . Given that PKC-q and MSK-1 are tethered to the proximal regulatory elements of immune response genes, we investigated the ability of these kinases to modulate H3S10p. Enforced expression of either PKC-q WT or the catalytically inactive KR displayed minimal effects on H3S10p levels compared to a vector only (V) control ( Figure 5A ). However, when MSK-1 binding was monitored, only partial impairment was detected in the KR mutant samples ( Figure 5A ). This suggests that the histone kinase MSK-1 may contribute to H3S10p on the CD69 promoter independently of PKC-q. Inhibition of MSK-1 with H89 successfully blocked H3S10p at the CD69 promoter ( Figure 5B ). This is consistent with previous studies of H89 for other early response genes (Thomson et al., 1999) and can be attributed to the lack of MSK-1 recruitment to this promoter in the presence of H89 ( Figure 5C ). In support of our earlier transfection studies, pretreatment with the PKC-q ATP inhibitor Rottlerin (Springael et al., 2007) failed to block H3S10p at the CD69 promoter ( Figure 5D ). In addition, Rottlerin did not diminish PKC-q binding on this gene ( Figure 5E ). Together, these data suggest that the region encompassing the KR mutation within the PKC-q catalytic core may be involved in tethering this kinase to chromatin.
Since active PKC-q appears to be essential for recruitment of transcription components, we assessed the ability of this kinase to influence chromatin accessibility by CHART-PCR. Pretreatment with Rottlerin abrogated the chromatin accessibility across the CD69 and TNF-a proximal promoters as well as inhibiting their messenger RNA (mRNA) production after T cell activation ( Figure 5F and Figure S2 , respectively). In contrast, H89 treatment failed to inhibit the chromatin accessibility in the promoter regions after activation and had minimal effect on mRNA production ( Figure 5F and Figure S2 ). Our results suggest that PKC-q activity, but not that of MSK-1, appears to facilitate chromatin accessibility and accompanying mRNA production of inducible immune response genes. This process seems to be independent of serine-10 phosphorylation mediated by MSK-1. A recent study found that PKC-b 1 associates with chromatin and this dictates the action of the chromatin-modifying enzyme LSD-1 in HeLa cells (Metzger et al., 2010) . Thus, to further support the interplay between PKC-q with chromatin associated proteins (MSK-1, Pol II, 14-3-3z, and LSD-1) in T cells, we performed PKC-q-specific RNA interference (RNAi) in resting and activated T cells in conjunction with ChIP. PKC-q was inhibited by RNAi treatment, as monitored by PKC-q Taq-Man real-time PCR ( Figure S3 ). Inhibition of PKC-q with RNAi successfully diminished binding of this kinase to the IL-2 promoter, as well as inhibiting MSK-1, Pol II, 14-3-3z, and LSD-1 occupancy on this target gene ( Figure 5G ). To gain a better mechanistic understanding of the interplay of PKC-q with MSK-1, we performed ChIP for PKC-q, MSK-1, Pol II, 14-3-3z, and LSD-1 with MSK-1 RNAi. Depletion of MSK-1 further supported the interdependence of PKC-q and MSK-1, which also appeared important for the inducible association of Pol II, 14-3-3z, and LSD1 ( Figure 5H ). 14-3-3 RNAi only led to marginal diminution of the PKC-q chromatin associated complex at the ChIP level ( Figure S4 ) and there was no effect on transcription of the inducible gene, IL-2, in these cells ( Figure S4 ). This is not surprising considering that this RNAi does not specifically target the 14-3-3z isoform, which we have shown thus far to form a complex with PKC-q on a chromatin template. In contrast, depletion of either PKC-q or MSK-1 resulted in decreased transcription of the IL-2 cytokine, consistent with the disassembly of an active complex in the absence of either of these two proteins ( Figures  5I and 5J , respectively). These RNAi data complement our inhibitor and PKC-q mutant data, which all demonstrate that PKC-q association with chromatin is likely to be required for the stable binding of MSK-1, Pol II, 14-3-3z, and LSD-1.
Genome-wide ChIP-on-Chip Reveals that PKC-qp Coresides with Pol II on the Promoter and Transcribed Regions of Active Genes and MicroRNAs
Having identified a nuclear role for PKC-q in the active transcription of several key immune genes, we determined whether PKC-q's association with chromatin is a genome-wide phenomenon in activated T cells. ChIP-on-chip (GEO accession number GSE26035) identified only 141 genes bound by PKC-qp with a p value score of < 0.05 and an enrichment ratio > 5 (Table S1 ). Constitutively expressed genes, including b-actin, GAPDH, and cyclophilin A, were not enriched within the PKC-qp-bound subsets. The inducible immune response genes, CD69, heparanase, TNF-a, and IFN-g, were all present in the PKC-qp-bound subset of genes, with enrichment ratios < 5 and p values < 0.05. Close examination of the classes of DNA regions bound by PKC-qp showed that PKC-qp is enriched at promoter, 5 0 -transcribed, and downstream regions of a subpopulation of genes, with the majority of binding (61%) detected in transcribed regions ( Figure 6A ). The top 50 ranked genes based on PKC-qp binding to either the 5 0 -transcribed or promoter regions are depicted in Figure 6B (p < 0.01). Functional annotation of the PKC-qp target genes ( Figure 6A ) revealed that this kinase interacts with genes linked to specific cellular processes, such as cell-cell communication, programmed cell-death, signal transduction, mesenchymal cell development, and differentiation ( Figure 6C ). The top-ranking PKC-qp-bound gene in the promoter was the innate immune receptor TREML4, which has been shown to play a crucial role in fine-tuning inflammatory responses (Ford and McVicar, 2009 ). In addition, PARP-10, a novel interacting partner of myc that is dysregulated in numerous human cancers (Yu et al., 2005) was identified as one of the top ranking genes in the transcribed region. A subset of the top 50 ranked PKC-qp-bound genes encoded signaling proteins (e.g., LCK, DGKD, CDC25A, CAMK2A, and SKIP), adhesion molecules, as well as the chromatin-associated enzyme RPS6KA1 and the epithelial to mesenchymal transition (EMT) inducer DNMT3A (Doehn et al., 2009) . PKC-qp also was found to associate with genes encoding proapoptotic molecules, such as YWHAZ, a 14-3-3 family member, and DDAH2. This kinase bound to the regulatory regions of genes that express proteins critical for EMT progression and cancer development, including the WNT family (WNT5A, WNT3, WNT2B, WNT7B, and WNT10A), cadherin members, and to oncogenic transcription factors such as RUNX2 and KLF9.
Since our initial studies suggested that the presence of PKC-qp and Pol II were intimately linked to the promoters and transcribed regions of inducible genes in T cells, we performed Figure 1C . All ChIP data were calculated as n-fold enrichment ratio of immunoprecipitated DNA relative to no antibody control, normalized against total input DNA. NS ChIP enrichment was set to 1 for sequential ChIP. ChIP data with error bars are shown as the mean ± SE of two independent experiments, otherwise representative of at least two independent experiments performed in duplicate. See also Figure S1 . 
Molecular Cell
PKC-q Binds Target Genes and MicroRNAs in T Cells
ChIP-on-chip of genome-wide Pol II binding in activated T cells. Consistent with our initial findings, 62% of the 141 genes that bound PKC-qp (Table S1) were also occupied by Pol II, with both molecules colocalizing to the same region of most genes ( Figure 6D ).
Of particular interest, PKC-q bound to the proximal regulatory regions of 60 microRNAs in activated T cells (listed in Table S2 ). PKC-q binding was most prevalent in the promoter, as opposed to the coding region, of the microRNA genes and this was closely correlated with Pol II binding ( Figure 6E and Table S2 ). The top five ranked microRNAs in each binding category are listed in Figure 6E . Importantly, a number of these microRNAs have been closely linked with EMT and cancer, including miR-200b/c, miR-141, and miR-429 from the same family and miR-9-1, miR-9-3, and miR-205. Based on the specific functions of a cohort of PKC-q target genes identified in the ChIP-on-chip data, we surmised that PKC-q may function as a mediator in EMT transition. To test this hypothesis, cell morphology was examined in control (mock) and PKC-q wild-type (WT) transfected MCF-7 cells by phase-contrast microscopy 48 hr posttransfection. As is typical of this human epithelial breast cancer cell line, mock-transfected cultures formed tightly packed clusters of cobblestone-shaped cells ( Figure 6F) . In contrast, overexpression of PKC-q caused a clear morphological change, with transfected cells acquiring an irregular but elongated shape and loss of cell-cell contact ( Figure 6F ). There was visibly less cell clustering observed, with cell scattering suggesting increased motility. The effect of overexpression of PKC-q was comparable to that obtained by treating cells with TNF-a ( Figure 6F ), which has been reported previously to induce motility and invasive behavior in MCF-7 cells (Yin et al., 2009) . Cell motility was further evaluated by an in vitro wound-healing assay. In PKC-q transfected cells, substantial wound closure ($80%, Figure 6G and Figure S5 ) was observed after 60 hr, compared with wound closure in mock-transfected cultures ($20%, Figure 6G and Figure S5 ). PKC-q induced cell motility more effectively than TNF-a alone, which induced only $40% of wound closure in mocktransfected cells ( Figure S5) ; however, TNF-a did not further enhance the effect of PKC-q ( Figure S5 ). Our genome-wide analysis, in conjunction with our functional studies, suggests that PKC-q is coupled to processes that regulate EMT and microRNA regulation.
PKC-q Participates in a Signaling Complex that Negatively Regulates MicroRNAs
MicroRNAs are small noncoding RNAs that generally act as posttranscriptional repressors of gene expression either via reduction of their target transcripts, prevention of the target protein translation, or both. Since we have identified a distinct cohort of microRNAs in our ChIP-on-chip that are direct gene targets of PKC-q, we investigated the transcript expression characteristics of the three microRNAs that exhibited the most significant PKC-q binding. When the transcript abundances of these microRNAs were measured in resting and P/I-stimulated T cells, they decreased in a stimulus-dependent manner ( Figure 7A ). To confirm PKC-q mediated regulation of these microRNAs at the transcript level, we employed pharmacological blockade and overexpression strategies. Jurkat T cells treated with the PKC-q inhibitor Rottlerin increased expression of these microRNAs, whereas treatment with the MSK-1 inhibitor H89 had no effect ( Figure 7B) . Conversely, overexpression of PKC-q in cells transfected with the vector overexpressing PKC-q (WT) decreased levels of these microRNAs compared to the vector control (V) samples (Figure 7C ). Together these findings support the notion that PKC-q negatively regulates these microRNAs in T cells.
Recent studies show that miR-200c and miR-9 repress the transcription of two transcription factors, Zeb1/Zeb2 for miR-200c and Onecut2 for miR-9 (Gregory et al., 2008; Plaisance et al., 2006) . Given that these transcription factors play a key role in the regulation of inducible genes (Furuno et al., 2008) , such as IL-2, we hypothesized that such microRNAs may participate in the regulation of inducible immune response genes. Inducible gene expression profiles were measured in Jurkat T cells after transfection of two of the most significant PKC-qbound synthetic microRNA precursors (miR-200c and miR-9) . At 48 hr posttransfection, with either the synthetic Pre-miRs or a scrambled Pre-miR (mock), total RNA was extracted for TaqMan real-time qPCR either before (NS) or after stimulation with P/I for 2 hr (ST). In parallel, miR-1 Pre-miR was used as a positive control to show that it successfully reduces PTK9 transcript levels ( Figure S6A ). Enforced expression of Pre-miR-200c markedly increased IL-2 and IFN-g expression in stimulated Jurkat T cells ( Figure 7D ). The heparanase gene exhibited elevated expression in both resting and activated T cells as a consequence of Pre-miR-200c overexpression ( Figure 7D ). This is consistent with our previous report that heparanase has a high level of basal transcription (Sutcliffe et al., 2009) . In contrast, miR-200c had little effect on TNF-a and CD69 mRNA production ( Figure 7D ). Previous studies have shown that miR-200c reduces transcript levels of the transcriptional repressors Zeb1/Zeb2, consequently elevating E-cadherin mRNA production (Gregory et al., 2008) . Since Zeb1 is also a critical repressor of IL-2 in T cells, we tested whether Zeb1 is also a target of miR-200c in T cells. Consistent with previous findings, transfection of Jurkat T cells with Pre-miR-200c had markedly repressed Zeb1 transcription, compared with mock samples ( Figure 7E ). Zeb2 was not found to be a target of miR-200c in Jurkat T cells (data not shown).
Transfection of Pre-miR-9 significantly increased CD69 and TNF-a expression in Jurkat T cells, whereas IL-2 and IFN-g were unaltered compared to the corresponding mock-transfected control ( Figure 7F ). Heparanase also displayed increased expression in both resting and activated T cells when Pre-miR-9 was overexpressed ( Figure 7F ). Consistent with previous (F) CHART on Jurkat nuclei from NS or 4 hr P/I left untreated or pretreated with Rottlerin (ROTT) or H89 across CD69 and TNF-a (À0.15 Kb). Data are graphed as the percentage change in accessibility and plotted as the mean ± SE of two independent experiments performed in duplicate. (G) Jurkat T cells transfected with scrambled RNAi (mock) or PKC-q RNAi and subsequently left untreated (NS) or stimulated for 2 hr with P/I (ST). ChIP with PKC-q, MSK-1, Pol II, 14-3-3z, and LSD1 antibodies across IL-2 (À0.15 Kb). CAMK2A  PCBP4  WDR5  WNT10A  CACNA1B  CNKSR1  CRAT  DGKD  ENTPD3  EXOSC4  LCK  POU4F2  PXK  RUNX2  CDC25A  KLF9  FRAS1  GRRP1  LCN2  ORC4L  RGS12  TREML4  YWHAZ  ZNF79 findings, miR-9 appears to mediate its affect by inhibiting transcription of the transcription factor onecut2 in T cells (Figure S6B) . Transfection of the Pre-miR200c into Jurkat T cells that were subsequently activated with P/I for 2 hr inhibited Zeb-1 occupancy on the IL-2 promoter and PKC-q concomitantly increased in occupancy ( Figure 7G ). This correlates with the ability of PKC-q to positively regulate its target genes. Transfection of the Pre-miR200c also diminished the repressive mark H3K9me2 across the IL-2 promoter, collectively correlating with increased transcription of this gene ( Figure 7D ).
DISCUSSION
It is widely understood that protein kinases are cytoplasmic intermediates of signal transduction cascades, relaying information from the cell surface to the nucleus for modulation of gene expression programs. We have now shown that the signal transduction kinase PKC-q, which is predominantly expressed in T cells and is best known for its critical role in CD4 + T cell responses, belongs to an emerging class of signaling kinases in mammalian cells that possess additional roles beyond modification of DNA binding regulatory proteins. We provide evidence of a nuclear role for PKC-q as an integral component of transcription complexes assembled at the control regions of immune genes and genes encoding microRNAs. Specifically, we have shown that recruitment of PKC-q to these inducible T cell genes (1) is dependent on continuous T cell activation signals, (2) requires the catalytically active domain of PKC-q, (3) forms an active transcription complex with MSK-1, Pol II, 14-3-3z, and LSD1, and (4) is required for inducible chromatin accessibility at proximal promoters. These results parallel the previously unrecognized nuclear roles for the NF-kB signaling kinases IKK-a and NIK (Anest et al., 2003; Yamamoto et al., 2003) and the protein kinases Cyclin A-Cdk2 identified in promoter complexes on mammalian genes (Lawrence et al., 2008) . The enzymatically active form of PKC-q bound transiently to the promoter region of CD69 in response to T cell activation, but showed even greater binding to the transcribed region of the gene, which persisted even after 24 hr of T cell stimulation. In contrast, the PKC-q kinase inactive mutant was not recruited to CD69, suggesting that the catalytic activity of PKC-q is required for binding to chromatin. This is also true of other yeast protein kinases, whose stable association with chromatin in promoter complexes requires them to be in an active form (Lawrence et al., 2008) . ChIP-on-chip further showed that PKC-qp localizes to the promoter and transcribed regions of active genes. Recent work has also shown that protein kinases, such as the stress-induced MAP kinase, Hog1, associate with the transcribed regions of activated target genes (Alepuz et al., 2001; Proft et al., 2006) . These data suggest that such features of PKC-q may facilitate efficient transcriptional output by binding to gene control regions in the nucleus.
PKC-q and MSK-1 appear to be highly dependent on one another to remain tethered to chromatin in activated T cells. Knockdown of either kinase resulted in the disassembly of the active transcription complex at the IL-2 promoter. MSK-1 has previously been shown to modify chromatin architecture by phosphorylating H3S10 on the nucleosomes of the immediateearly genes (Thomson et al., 1999) . While the MSK-1 inhibitor, H89, reduced H3S10p across the CD69 promoter, levels were unaffected by PKC-q activity blockade by Rottlerin or by the kinase-dead PKC-q mutant. This is in contrast to another study that has shown that histone H3 phosphorylation of osmoticstress response genes is blocked by Rottlerin (Burkhart et al., 2007) . It is possible that the role of PKC-q is gene and cell specific, as has been demonstrated for nuclear p38a (Simone et al., 2004) . While PKC proteins have been shown to phosphorylate histones in vitro, the exact nature of the histone posttranslational modifications (PTMs) induced by PKC-q at activated T cell gene targets remains to be identified.
The specific mechanisms that control the recruitment of signaling kinases to chromatin remain elusive. Numerous models have been proposed to explain the way in which signaling kinases are targeted to DNA (Pokholok et al., 2006) . PKC-q and MSK-1 could be recruited to chromatin by PTMs or by transcription factors (TFs) in a T cell activation-dependent manner. Detailed TFBS analyses of PKC-q gene targets identified by ChIP-on-chip revealed a cluster of TFs that are overrepresented in this gene subset (data not shown). Thus, PKC-q and MSK-1 may associate with gene promoters through direct interactions with TFs, such as MAZ, Sp1, EKLF, and the NF-kB family members (data not shown). In yeast, the Hog1 kinase binds to TFs bound to target gene promoters and can also stimulate recruitment of Pol II, associate with components of the elongation complex and regulate transcription initiation (Alepuz et al., 2003; Proft et al., 2006) . As such, kinases may enter the coding regions of genes by ''piggybacking'' with Pol II (Edmunds and Mahadevan, 2006) . It is possible that PKC-q may travel with the Pol II elongation complex through the coding regions of genes upon T cell activation. In support, we have shown that recruitment of PKC-q and MSK-1 to the transcribed regions of the heparanase and CD69 genes is dependent on Pol II elongation, as treatment of cells with Actinomycin D prevented the recruitment of these kinases beyond the transcriptional start site of the CD69 gene (data not shown). Moreover, our ChIPon-chip data shows a close correlation between the occupancy profiles of both PKC-q and Pol II in their active states. We can speculate that PKC-q may behave like a chromatin remodeller or structural adaptor by traveling with Pol II through the coding regions of genes upon transcriptional activation. Indeed, we found that PKC-q was essential for inducing chromatin accessibility across the proximal promoters of several immune genes.
An alternate means of modulating gene expression is post-transcriptionally through the action of microRNAs. Our (D) Correlation between PKC-q with Pol II-bound genes from duplicate microarray experiments. (E) PKC-q targeted microRNAs (p < 0.05, n = 2) either PKC-q bound or PKC-q & Pol II bound. (F) Phase-contrast microscopy of MCF-7 cells transfected with mock or WT and left untreated or treated for 24 hr with TNF-a. (G) MCF-7 cells transfected with mock or WT and analyzed by the wound-healing assay. Images were taken at zero hr (red line) and after 60 hr (green line). See also Tables S1 and S2 and Figure S5 . ChIP-on-chip data showed that PKC-q bound preferentially to the control regions of not only protein-coding genes, but also the promoter regions of microRNAs. The mRNA expression of three microRNA targets of were inversely correlated with both T cell activation and with overexpression of PKC-q, and were upregulated in response to Rottlerin (but not MSK-1) treatment of cells, suggesting a role for PKC-q in the negative regulation of these RNAs. Furthermore, enforced expression of miR-200c and miR-9 resulted in the induction of activated T cell genes, suggesting that these microRNAs are essential for inducible gene regulation. Previous studies have shown that miR-200c and miR-9 may operate via the regulation of T cell repressor proteins, Zeb1, Blimp1, and Onecut2. Indeed, enforced expression of miR-200c repressed Zeb1 expression in both resting and activated T cells, while miR-9 successfully repressed Onecut2 and Blimp1 (N.S. and A.D.K., unpublished data). Given that Zeb1 and several of these PKC-q-bound microRNAs are central players in tumor metastasis (Gregory et al., 2008) , we used wound-healing assays on human epithelial breast cancer cells to show that PKC-q may play a functionally relevant role in EMT processes. Our findings lend support to a model ( Figure S7 ) whereby chromatin anchored PKC-q is likely to regulate inducible T cell gene transcription by two opposing mechanisms: (1) positive regulation of inducible immune response genes as an active participant in chromatin-tethered transcription complexes in addition to its signaling role and (2) negative regulation of genes encoding transcriptional repressor proteins through microRNAmediated processes. Since the overall outcome is increased transcription of inducible genes, it is plausible that PKC-q functions as a modulator to fine-tune inducible gene regulation, both to initiate transcription, but also to control the response by increasing the level of cytokine repressor proteins by downregulating microRNA expression in a T cell activation-dependent manner. The timing of these competitive processes would ultimately prevent aberrant transcription ensuring the production of appropriate levels of cytokines required for T cell activation.
In summary, we have identified an alternate mechanism of action of the signal transduction kinase, PKC-q, as a component of the nuclear transcription machinery assembled at gene control regions in activated T cells. Future studies will aim to identify other components of the nuclear PKC-q transcription complex, and to determine the way in which the nuclear and cytoplasmic actions of PKC-q are coordinated and integrated to achieve the appropriate physiological response, especially in human memory T cell subsets. Finally, it remains to be deter-mined whether nuclear roles in gene expression are intrinsic to all PKC family members.
EXPERIMENTAL PROCEDURES
Cell Culture Human Jurkat T cells and mammary adenocarcinoma MCF-7 cells were cultured and stimulated as previously described (Sutcliffe et al., 2009) . For H89 (Sigma-Aldrich) and Rottlerin (Calbiochem) studies, cells were pretreated with 15 mM of each for 1 hr prior to stimulation. In the stimulation withdrawal experiment, cells were washed extensively 5 times in warm complete media and recultured in medium without stimulus for 16 hr (SW).
Immunofluorescence
Intracellular staining on $1 3 10 6 whole cells or isolated nuclei was performed as detailed previously (Rao et al., 2001) . These were fixed in 2% paraformaldehyde (pH 7-8) and centrifuged onto 0.1% poly-L-lysine coated coverslips. Whole cells or nuclei were permeabilized with 1% Triton X-100 and incubated with blocking buffer for 45 min at room temperature. Primary and secondary antibody details are provided in the Supplemental Experimental Procedures.
Total RNA Isolation and Quantitative Real-Time PCR Total RNA was extracted, and real-time PCR was performed as previously described (Sutcliffe et al., 2009 ). MicroRNA assays were performed with the TaqMan MicroRNA Reverse Transcription Kit (ABI 4366596). MicroRNA data were normalized to RNU6B.
Chromatin Accessibility by Real-Time PCR Accessibility of DNA to digestion with micrococcal nuclease (MNase) was analyzed with chromatin accessibility by real-time PCR (CHART-PCR) as described previously (Rao et al., 2001; Sutcliffe et al., 2009 ).
ChIP Assays
ChIPs were performed according to the protocol supplied by Upstate Biotechnology, as previously detailed (Sutcliffe et al., 2009) . Antibody details are provided in the Supplemental Experimental Procedures.
ChIP-on-Chip
Catalytically active PKC-q and Pol II ChIP DNA generated from P/I-stimulated Jurkat T cells were pooled from five independent ChIPs that were first individually validated by real-time PCR. Pooled DNA was subsequently amplified based on one round of the whole genome amplification method with the WGA2 kit (Sigma-Aldrich). Duplicate samples were hybridized onto Agilent human promoter microarrays that span 17,000 well-characterized genes (À5.5 to +2.5 Kb from TSS) from the human genome, as described in the Mammalian ChIP-on-chip protocol (version 9.1; Agilent Technologies).
ACCESSION NUMBERS
Microarray data have been under GEO accession number GSE26035. 
